Shankar Siva (@_ShankarSiva)

Pinned

S

Shankar Siva@_ShankarSiva · Mar 12, 2024

1/ Thank you 🙏🏾, patients, families, and investigators, for contributing to the SEISMIC 🫁trial out now @LancetRespirMed - shorturl.at/qxMUY. Led by 🫁@DanSteinfort, this international multicentre recruited n=155 trial from 🇦🇺, 🇨🇦, 🇺🇸, 🇳🇱 #radonc @tssmn @PeterMacRadOnc

_ShankarSiva's tweet image. 1/ Thank you 🙏🏾, patients, families, and investigators, for contributing to the SEISMIC 🫁trial out now @LancetRespirMed - shorturl.at/qxMUY. Led by 🫁@DanSteinfort, this international multicentre recruited n=155 trial from 🇦🇺, 🇨🇦, 🇺🇸, 🇳🇱 #radonc @tssmn @PeterMacRadOnc

14

94

233

42

52.0K

Shankar Siva Retweeted

T

Thoracic Oncology Group of Australasia@TOGAANZ · Jul 19

Prof Siva talks about the bold beginnings of the PRIME Lung trial and what happened next. 🎙️ Tune in to our latest episode to hear more. Listen on Apple: buff.ly/IxOhSRb Spotify: buff.ly/01rft49 Read show notes: buff.ly/0CYZlec

0

8

19

1

1.0K

S

Shankar Siva@_ShankarSiva · Jul 18

Of course!!!! 😄

DDrew Moghanaki@DrewMoghanaki · Jul 17

Is it true that this is one of the most important SABR events in the world? @_ShankarSiva

0

4

0

1.0K

S

Shankar Siva@_ShankarSiva · Jul 17

Is it true that this is one of the most important SABR events in the world? @_ShankarSiva

SShankar Siva@_ShankarSiva · Jun 29

#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…

2

4

14

2

4.0K

S

Shankar Siva@_ShankarSiva · Jul 16

Is this event sold out already? @_ShankarSiva

SShankar Siva@_ShankarSiva · Jun 29

#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…

1

2

0

2.0K

S

Shankar Siva@_ShankarSiva · Jun 29

#SABR2025 registrations are open #radonc!! sabrsymposium.com - Come join us @PeterMacCC @PeterMacRadOnc on Nov 14th-15th. We have a phenomenal international faculty line up 🇺🇸🇨🇦🇮🇹🇫🇷🇦🇺with @PBlanchardMD @lauren_henke, @BarbaraJereczek, @DrewMoghanaki and @Melissa_O_Neil.…

_ShankarSiva's tweet card. Peter MacCallum Cancer Centre has been running highly successful symposia on Stereotactic Ablative Body Radiation Therapy (SABR) since 2014. In November we will once again host the SABR Symposium in...

4

24

78

4

15.0K

Shankar Siva Retweeted

C

Constantinos Zamboglou@CZamboglou · Jul 11

Excited to share our newest paper on digital pathology AI biomarkers in prostate cancer RT. In this work we: ▶️performed a systematic review ▶️checked ongoing trials ▶️collected an expert consensus sciencedirect.com/science/articl… Thanks @RO_GreenJournal for accepting this work

3

16

42

12

5.0K

Shankar Siva Retweeted

D

Drew Moghanaki@DrewMoghanaki · Jul 12

Why is World Radiotherapy Day happening on September 7th? It’s because 9/7/1953 is the day the first patient was ever treated with a modern linear accelerator at Hammersmith Hospital in London. #WorldRTDay #WRAD #OneVoiceForRadiotherapy Ref: jpneylon.github.io/ABR/PDFs/Artic…

2

26

72

14

4.0K

Shankar Siva Retweeted

F

Felix Ehret@FelixEhretMD · Jul 13

Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! @ASTRO_org @ESTRO_RT @the_RSS @bslotman @SimonLo21054188 @EbnerMD @PercyLeeMD @_ShankarSiva @TugceKutukMD practicalradonc.org/article/S1879-…

3

31

86

41

3.0K

Shankar Siva Retweeted

Y

Yakup Ergün@dr_yakupergun · Jul 3

A newly published "review" article: 🔹️Fully funded and written with company support 🔹️Includes company employees as co-authors 🔹️Medical writing outsourced and paid for 🎗 Yet declares: "no conflicts of interest" 🫣And it's published in one of the highest-impact journals…

2

21

62

10

11.0K

S

Shankar Siva@_ShankarSiva · Jul 3

Everything that’s wrong with academic publishing these days.

YYakup Ergün@dr_yakupergun · Jul 3

A newly published "review" article: 🔹️Fully funded and written with company support 🔹️Includes company employees as co-authors 🔹️Medical writing outsourced and paid for 🎗 Yet declares: "no conflicts of interest" 🫣And it's published in one of the highest-impact journals…

5

6

36

3

8.0K

Shankar Siva Retweeted

E

European Urology Oncology@EurUrolOncol · Jul 3

🚨 New in European Urology Oncology: Is SBRT ready for primary RCC? With 5-year local control rates nearing 96%, it's a game-changer for inoperable cases—but the lack of final pathology may limit adjuvant therapy options. 🔗 Read the editorial: euoncology.europeanurology.com/article/S2588-… #UroOnc…

1

21

51

25

5.0K

Shankar Siva Retweeted

M

Muhammad Ali@dr_alimuhammad · Jul 3

Our article to look at the impact of tumour complexity on outcomes following SABR for primary kidney cancer @_ShankarSiva @declangmurphy @PeterMacRadOnc @PeterMacCC bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

1

7

13

3

1.0K

Shankar Siva Retweeted

D

David Palma, MD, PhD@drdavidpalma · Jul 4

I learned this week that SABR-COMET patient #1 recently passed away, more than 12 years after enrollment, with no recurrence since his original SABR. We initially treated him for a left adrenal met. It’s an interesting story… ⬇️⬇️⬇️

17

75

274

45

27.0K

Shankar Siva Retweeted

F

Filippo Alongi@alongi_filippo · Jun 30

I was there, a few years ago: do not miss !!

0

3

7

0

1.0K

Shankar Siva Retweeted

K

Kidney Cancer@KidneyCancer · Jun 26

💥We're thrilled to partner with @ASTRO_org for a special joint session on radiotherapeutic innovations in #kidneycancer! Register for #ASTRO25 (early rate ends today) in September and join us for an exciting panel and discussion! 👉astro.org/meetings-and-e…

2

7

18

0

1.0K

S

Shankar Siva@_ShankarSiva · Jun 26

Looks who’s back!!! #radonc

DDavid Palma, MD, PhD@drdavidpalma · Jun 23

I decided to rejoin X because there just isn't the same #radonc community on the other platforms. Over the next couple of days, I'll post some updates on some research and the ARC Bootcamp. Thanks @_ShankarSiva for the nudge to come back!

1

3

27

0

2.0K

S

Shankar Siva@_ShankarSiva · Jun 26

Congrats to @_ShankarSiva, A/Prof Arun Azad and the TROG 19.06 DECREASE trial on reaching recruitment for the trial - a fantastic effort from all involved.

SShankar Siva@_ShankarSiva · Jun 25

🥳 Today, we randomised the final patient on @TROGfightcancer 19.06 DECREASE trial! This trial randomised patients with prostate cancer who were becoming resistant to hormone therapy, without evidence of metastases on bone or CT scan, to Darolutamide +/- Stereotactic…

0

2

8

0

872

S

Shankar Siva@_ShankarSiva · Jun 25

🥳 Today, we randomised the final patient on @TROGfightcancer 19.06 DECREASE trial! This trial randomised patients with prostate cancer who were becoming resistant to hormone therapy, without evidence of metastases on bone or CT scan, to Darolutamide +/- Stereotactic…

_ShankarSiva's tweet image. 🥳 Today, we randomised the final patient on @TROGfightcancer 19.06 DECREASE trial! This trial randomised patients with prostate cancer who were becoming resistant to hormone therapy, without evidence of metastases on bone or CT scan, to Darolutamide +/- Stereotactic…

9

34

128

11

8.0K

S

Shankar Siva@_ShankarSiva · Jun 20

👏🏽👏🏽👏🏽 agree! it’s time to retire the “toxicity” moniker #radonc. We are stuck in the past!!!! @sueyom @NehaVapiwala

DDrew Moghanaki@DrewMoghanaki · Jun 19

It is beautiful to see a fellow Penn alumn use the word "Safety" in the title of a #radonc publication. Kudos to Dr. Yeboa and colleagues for sending a positive message about stereotactic radiation therapy! @sueyom @NehaVapiwala pubmed.ncbi.nlm.nih.gov/40531511/

2

10

52

5

5.0K